News & Views

 

featured

Embracing the Intersections of Innovation: Our Investment in Nautilus Biotechnology

- Matt McIlwain

More views  
March 14, 2019

Pictured l-r S. Somasegar, Ted Kummert, Chris Picardo, Barry Wark (seated) Winston Brasor

We are excited to announce today our investment in Ovation.io, a company that is building the next-generation suite of cloud-based clinical informatics tools for the genomic and molecular testing industry…. READ MORE